A Phase 1 Study of Temsirolimus in Combination With Irinotecan and Temozolomide in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors.

Trial Profile

A Phase 1 Study of Temsirolimus in Combination With Irinotecan and Temozolomide in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Apr 2015

At a glance

  • Drugs Irinotecan (Primary) ; Temozolomide (Primary) ; Temsirolimus (Primary)
  • Indications CNS cancer; Glioma; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 14 Nov 2013 Planned end date changed from 1 Nov 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 14 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 May 2012 Planned End Date changed from 1 May 2011 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top